Erratum: How a Novel Portable Spacer Benefits Patients with Respiratory Disease, the Healthcare System, and the Environment - European Medical Journal

This site is intended for healthcare professionals

Erratum: How a Novel Portable Spacer Benefits Patients with Respiratory Disease, the Healthcare System, and the Environment

Author: EMJ

Citation: EMJ. 2025. https://doi.org/10.33590/emj/DRHK2203

Date correction published: 11/11/2025

Original publication¹

In the KOL interview article1 published on the EMJ website on 11th September 2025, an error has been identified in Figure 2.

Figure 2 was originally incorrectly cited as reference 14 of the article.2

The Figure has now been updated and correctly cited as reference 13 of the article.3

EMJ apologises for the error and any inconvenience caused.

Reference:

1. Wang S, Suggett J. How a Novel Portable Spacer Benefits Patients with Respiratory Disease, the Healthcare System, and the Environment. EMJ. 2025;10[3]:35-41.
2. Eikholt A et al. Usability and acceptance of a novel compact spacer in patients with asthma and/or COPD. Eur Respir J. 2023;62(Suppl 67):PA4604.
3. Suggett J, Ellery A. Improved adherence and high patient satisfaction with ‘on the go’ spacer. Poster Group 8. Canadian Respiratory Conference, 2023.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.